Emory tops U S News & World Report s list of best Atlanta hospitals ajc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajc.com Daily Mail and Mail on Sunday newspapers.
Atlanta s 500 Most Powerful Leaders in 2023: Education & Healthcare atlantamagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from atlantamagazine.com Daily Mail and Mail on Sunday newspapers.
Tags »
Emory University is participating in a study evaluating immune responses to COVID-19 vaccines, when the vaccines are administered during pregnancy or within two months after delivery.
The study, called SARS-CoV-2 Vaccines in Pregnancy and Postpartum or MOMI-Vax, is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. MOMI-Vax is being conducted by the NIAID-funded Infectious Diseases Clinical Research Consortium (IDCRC).
MOMI-Vax is open to people who have received any of the FDA-authorized COVID-19 vaccines. The early COVID-19 vaccine clinical trials generally excluded pregnant women, so there is limited data on immune responses for this special population. However, after the FDA authorized the vaccines, regulators gave people who were pregnant or soon to be pregnant the option of choosing to get the vaccines. Tens of thousands of pregnant and breastfeeding people across the country have b